Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€25.40

€25.40

3.250%
-
3.250%
€51.36
 
01.07.25 / Tradegate WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

QuidelOrtho Corp. Stock

A very strong showing by QuidelOrtho Corp. today, with an increase of €0.000 (3.250%) compared to yesterday's price.
We see a rather positive sentiment for QuidelOrtho Corp. with 7 Buy predictions and 1 Sell predictions.
With a target price of 51 € there is potential for a 100.79% increase which would mean more than doubling the current price of 25.4 € for QuidelOrtho Corp..
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of QuidelOrtho Corp. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of QuidelOrtho Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
QuidelOrtho Corp. 3.250% 4.098% -2.308% -13.014% -39.524% -72.718% -87.426%
Veeva Systems A -0.420% -0.208% -1.684% 40.658% 17.815% 22.280% 11.245%
Thermo Fisher Scientific Inc. 1.370% 2.881% 4.633% -27.028% -27.416% -31.028% 11.318%
Waters Corp. -0.860% -0.234% -0.766% 12.618% -16.170% 0.931% 85.155%

Comments

Prediction Buy
Perf. (%) -18.06%
Target price 38.843
Change
Ends at 08.05.26

QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Ratings data for QDEL provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 17.59%
Target price 21.785
Change
Ends at 21.04.26

QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $38.00 to $25.00. They now have an "underweight" rating on the stock.
Ratings data for QDEL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -36.55%
Target price 58.456
Change
Ends at 13.02.26

QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at Royal Bank of Canada from $64.00 to $61.00. They now have an "outperform" rating on the stock.
Ratings data for QDEL provided by MarketBeat
Show more

News

QuidelOrtho to Participate in Upcoming Investor Conferences: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Participate in Upcoming Investor Conferences


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

QuidelOrtho Reports First Quarter 2025 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports First Quarter 2025 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and

QuidelOrtho to Report First Quarter 2025 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Report First Quarter 2025 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company”) or (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and